Hepatobiliary Neoplasm — Trials

Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,266 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 1,906 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07733115	QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer	recruiting	Phase 2	38	Shanghai Zhongshan HospitalOTHER	1	Jul 29, 2026	clinicaltrials
NCT06506955	Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.	active not recruiting	Phase 2 / Phase 3	15	Taiho Oncology, Inc.INDUSTRY	5	Jul 28, 2026